# Ennovation Ventures

> Ennovation Ventures is a VC fund in Shanghai backing Medical, Health Care and Biotechnology. See 11 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Shanghai, China
- Total investments: 11
- Last investment: May 2026
- Lead investor: 36%
- Last updated: Aug 2026

Ennovation Ventures is a venture capital firm that focuses on biomedical and medical health.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 4 | 36% |
| Health Care | 3 | 27% |
| Biotechnology | 3 | 27% |
| Pharmaceutical | 2 | 18% |
| Database | 1 | 9% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 4 | 36% |
| Series A | 4 | 36% |
| Series B | 3 | 27% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sinzen Medtech | Sinzen Medtech is a medical technology company that specializes in minimally invasive surgical and tumor treatments. |  | Series A | May 19, 2026 |  |
| Proviva Therapeutics, Inc | Prodrug design platform for cytokines and other fusion proteins | $18M | Series A | Mar 05, 2024 |  |
| Hope Medicine | Hope Medicine is committed to researching, developing and commercializing the first innovative drugs aimed at improving the quality of life for a wide range of popular male and female diseases. | $28.1M | Series B | Feb 07, 2024 |  |
| Zenshine Pharma | Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases. |  | Series B | Mar 11, 2023 |  |
| Nanjing Orui Pharmaceutical | Nanjing Orui Pharmaceutical focuses on research and development of antiviral drugs with unique ideas. | $15.7M | Seed | Mar 27, 2022 |  |
| Human Zhizao | Human Intelligent Manufacturing is a fully automatic multiple flow fluorescence platform. |  | Seed | Mar 21, 2022 |  |
| InxMed | InxMed is a clinical-stage biotech company focusing on developing "Best-in-Disease Combination" medicines to bring novel treatment options for patients. Our innovations are inspired by patients and driven by an in-depth understanding of disease biology and pharmacology. InxMed is committed to building a translational platform equippedwith global-level top-notch know-how and efficient execution capabilities. | $50M | Series B | Mar 03, 2022 |  |
| Purui | Purui is a life big data service provider. | $14.2M | Seed | Feb 10, 2022 |  |
| Prime Lifescience | Prime Lifescience is a developer of a big data platform that focuses on life sciences. The company is dedicated to establishing a health lifecycle big data collaboration network through digital technology innovation and extensive use of artificial intelligence. They offer a digital smart health community, a digital intelligent clinical researchaccelerator, and a live big data platform as part of their offering. | $15.7M | Seed | Jan 28, 2022 |  |
| Zenshine Pharma | Zenshine Pharma is a clinical-stage biopharmaceutical company with a focus on the development of small molecule drugs for cancer, viral infections, and autoimmune diseases. | $15M | Series A | Dec 01, 2020 |  |

10 of 11 investments shown.

## Co-investors
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund, 4 deals together
- [AIHC Capital](https://shizune.co/investors/profile/aihc-capital) — VC Fund, 1 deal together
- [Beijing Huairou Science City Science and Technology Service](https://shizune.co/investors/profile/beijing-huairou-science-city-science-and-technology-service) — VC Fund, 1 deal together
- [China Growth Capital](https://shizune.co/investors/profile/china-growth-capital) — VC Fund, 1 deal together
- [CMG-SDIC Capital Management](https://shizune.co/investors/profile/cmg-sdic-capital-management) — VC Fund, 1 deal together
- [CS Capital](https://shizune.co/investors/profile/cs-capital) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)
- [Life Science Investors in Asia](https://shizune.co/investors/life-science-investors-asia)
- [Life Science VC Funds in Asia](https://shizune.co/investors/life-science-vc-funds-asia)

## FAQ

### What does Ennovation Ventures invest in?

Ennovation Ventures invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 11 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Ennovation Ventures last invest?

The most recent investment recorded for Ennovation Ventures closed in May 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co